Oxycodone News and Research

RSS
Researchers launch NIH-sponsored clinical trial for spinal deformity

Researchers launch NIH-sponsored clinical trial for spinal deformity

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

Labopharm's first-quarter fiscal 2010 revenues from product sales decrease $0.4M to $3.2M

Labopharm's first-quarter fiscal 2010 revenues from product sales decrease $0.4M to $3.2M

Additional pivotal Phase 3 trial data for MoxDuo IR released

Additional pivotal Phase 3 trial data for MoxDuo IR released

Florida Senate approves new abortion restrictions

Florida Senate approves new abortion restrictions

Mass. legislation to push poor seniors into managed care plans stirs concerns

Mass. legislation to push poor seniors into managed care plans stirs concerns

Stinging FDA review for Acurox – the implications

Stinging FDA review for Acurox – the implications

FDA rejects experimental painkiller Acurox

FDA rejects experimental painkiller Acurox

FDA Advisory Committees vote against approval of Acurox NDA

FDA Advisory Committees vote against approval of Acurox NDA

Labopharm launches INTELLITAB abuse and misuse-deterrent technology platform

Labopharm launches INTELLITAB abuse and misuse-deterrent technology platform

Covidien's second-quarter medical devices sales up 11%

Covidien's second-quarter medical devices sales up 11%

New formulation of controlled-release drug OxyContin approved

New formulation of controlled-release drug OxyContin approved

Conventional analgesics to drive acute pain market over the next decade

Conventional analgesics to drive acute pain market over the next decade

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

Collegium Pharmaceutical files IND for second opioid product using DETERx technology

Collegium Pharmaceutical files IND for second opioid product using DETERx technology

USPTO allows Pisgah Labs' patent application regarding imipramine pamoate

USPTO allows Pisgah Labs' patent application regarding imipramine pamoate

Single dose of Pain Therapeutics' PTI-188 decreased  melanoma tumors: Study

Single dose of Pain Therapeutics' PTI-188 decreased melanoma tumors: Study

Acurox NDA: FDA schedules Advisory Committee meeting

Acurox NDA: FDA schedules Advisory Committee meeting

BeaconEquity.com announces investment report featuring Intellipharmaceutics International

BeaconEquity.com announces investment report featuring Intellipharmaceutics International

Generic Focalin XR patent suit: Intellipharmaceutics International announces settlement

Generic Focalin XR patent suit: Intellipharmaceutics International announces settlement

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.